Premium
Early hypoglycaemia after accidental intramuscular injection of insulin glargine
Author(s) -
Karges B.,
Boehm B. O.,
Karges W.
Publication year - 2005
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2005.01654.x
Subject(s) - medicine , insulin glargine , insulin , diabetes mellitus , nph insulin , hypoglycemia , type 1 diabetes , subcutaneous injection , intramuscular injection , endocrinology , surgery
Aim Insulin glargine is a long‐acting insulin analogue with favourable clinical characteristics. We studied a slim 24‐year‐old female with Type 1 diabetes who repeatedly experienced severe hypoglycaemia after switching from NPH insulin to insulin glargine at identical daily doses. Methods Clinical examination and high‐resolution ultrasound. Results The patient frequently placed her injections into muscle tissue, followed by unexpected rapid insulin action. After correction of her injection technique, hypoglycaemia did not recur. Conclusions The long‐acting kinetics of insulin glargine require precipitation in the subcutaneous tissue. Therefore, each patient's injection technique should be carefully checked when treatment with insulin glargine is initiated, particularly in young and lean individuals.